Xvivo Perfusion AB (publ) ( XVIVO.ST) - Stock Earnings
XVIVO.ST Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 4.3 million SEK | 189.1 million SEK |
| 2025Q4 | 31.6 million SEK | 226.1 million SEK |
| 2026Q1 | 36.3 million SEK | 241.0 million SEK |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
XVIVO.ST Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 91.8 million SEK | 597.5 million SEK |
| 2024 | 172.2 million SEK | 822.4 million SEK |
| 2025 | 25.2 million SEK | 812.2 million SEK |
| 2026 Est. | — | — |
XVIVO.ST
Price: SEK277.60
52 week price:
Earnings Per Share: 2.33 SEK
P/E Ratio: 117.77
Exchange: STO
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 8.6 billion